DNA methylation in breast cancer

X. Yang, L. Yan, N. E. Davidson

Research output: Contribution to journalArticle

Abstract

Like all cancers, breast cancer is considered to result in part from the accumulation of multiple genetic alterations leading to oncogene overexpression and tumor suppressor loss. More recently, the role of epigenetic change as a distinct and crucial mechanism to silence a variety of methylated tissue-specific and imprinted genes has emerged in many cancer types. This review will briefly discuss basic aspects of DNA methylation, recent advances in DNA methyltransferases, the role of altered chromatin organization and the concept of gene transcriptional regulation built on methylated CpGs. In particular, we discuss epigenetic regulation of certain critical tumor suppressor and growth regulatory genes implicated in breast cancer, and its relevance to breast cancer diagnosis, prognosis, progression and therapy.

Original languageEnglish (US)
Pages (from-to)115-127
Number of pages13
JournalEndocrine-related cancer
Volume8
Issue number2
DOIs
StatePublished - Jul 24 2001

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Oncology
  • Endocrinology
  • Cancer Research

Fingerprint Dive into the research topics of 'DNA methylation in breast cancer'. Together they form a unique fingerprint.

  • Cite this

    Yang, X., Yan, L., & Davidson, N. E. (2001). DNA methylation in breast cancer. Endocrine-related cancer, 8(2), 115-127. https://doi.org/10.1677/erc.0.0080115